EDIT

Editas Medicine, Inc. · NASDAQ · Healthcare · USD · 10-K for 2025, filed 2026-03-09

Figures on this page computed 2026-11-08 12:40 UTC

Last close

2.72USD

Market data, 2026-11-04

Except where said otherwise: 10-K for 2025, filed 2026-03-09

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
- computed
- 10-K for 2025, filed 2026-03-09
The filing itself
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-09
- 10-K for 2025, filed 2026-03-09
- 10-K for 2025, filed 2026-03-09
- 10-Q for 2025, filed 2026-08-05
- 10-K for 2025, filed 2026-03-09
- 10-Q for 2025, filed 2026-08-05
The filing itself
-395.0%Net margin
Net Income / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-09
- 10-K for 2025, filed 2026-03-09
The filing itself
-409.3%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-09
- 10-K for 2025, filed 2026-03-09
The filing itself
2.81Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
- 10-K for 2025, filed 2026-03-09
- 10-Q for 2025, filed 2026-08-05
The filing itself
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-07
Reported in
USD
- computed

Safety is the furthest below its sector's middle: 0.30 against 0.58 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

1.13x

1.04x

1.35x

1.62x

0.14x

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Filed2025

Market data2026-11-04

Each against its own average

5 of 5 read

Except where said otherwise: 10-K for 2025, filed 2026-03-09

Sales1.13x
Its own average over 10 years, 35.9M.
Profit1.04x
Its own average over 10 years, -154.0M.
Free cash flow1.35x
Its own average over 10 years, -122.5M.
Debt1.62x
Its own average over 7 years, 47.3M.
Price0.14x
Its own average over 11 years, 19. Market data, 2026-11-04

Price is furthest from its own average, at 0.14 times.

Sales is 1.13 times its own 10-year average; Profit is 1.04 times its own 10-year average; Free cash flow is 1.35 times its own 10-year average; Debt is 1.62 times its own 7-year average; Price is 0.14 times its own 11-year average.

Every figure in this lens

Except where said otherwise: 10-K for 2025, filed 2026-03-09

Sales against its own 10-year average1.13
Source
filed
Statement
income
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
The filing itself
Profit against its own 10-year average1.04
Source
filed
Statement
income
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
The filing itself
Free cash flow against its own 10-year average1.35
Source
filed
Statement
income
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
The filing itself
Debt against its own 7-year average1.62
Source
filed
Statement
income
Fiscal year
2025
Accession
0001650664-26-000017
Reported in
USD
The filing itself
Price against its own 11-year average0.14Market data, 2026-11-04
Source
market
Taken on
2026-11-04
Reported in
USD